WEBINAR: Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery

Date: Tuesday, May 9, 2017
Time: 12:00 – 1:00 pm EST

Webinar Materials

Watch WebinarExternal Web Site Policy
View Presentation (PDF)External Web Site Policy
View Webinar Q&As (PDF)External Web Site Policy

Background

This webinar will provide an overview of the R01 and R21 notice of funding opportunities (NOFOs), Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery PA-17-060External Web Site Policy (R01) and PA-17-061External Web Site Policy (R21).

Dr. Wendy Nelson and Ms. Kathleen Castro provide an overview of these NOFOs that seek research to assess and describe the current state of oral anticancer medication utilization, delivery, and adherence; identify structural, systemic, and psychosocial barriers to adherence; and develop models and strategies to improve safe and effective delivery of these agents so that clinical outcomes are optimized.

Intended Audience

Extramural investigators at junior, mid-, and senior levels.

Email your questions in advance to ncidccpsbrpadvances@mail.nih.gov. Questions about specific aims or grant application details will not be addressed.

National Cancer Institute Speakers

Wendy Nelson

Wendy Nelson, PhD, MPHExternal Web Site Policy
Program Director
Basic Biobehavioral and Psychological Sciences Branch
Behavioral Research Program

Kelly Filipski

Kelly Filipski, PhD, MPHExternal Web Site Policy
Program Director
Clinical and Translational Epidemiology Branch
Epidemiology and Genomics Research Program

Kathleen Castro, RN, MS, AOCN®
Program Director
Office of the Associate Director
Healthcare Delivery Research Program

This webinar will be archived on the HDRP Events webpage.

Last Updated: 17 Jan, 2025